Vr Adviser, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $658 Million distributed in 33 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ocular Therapeutix, Inc with a value of $154M, Viridian Therapeutics, Inc.\De with a value of $83.5M, Kal Vista Pharmaceuticals, Inc. with a value of $81.3M, Oric Pharmaceuticals, Inc. with a value of $78.7M, and Cogent Biosciences, Inc. with a value of $57.4M.
Examining the 13F form we can see an increase of $153M in the current position value, from $505M to 658M.
Vr Adviser, LLC is based out at New York, NY
Below you can find more details about Vr Adviser, LLC portfolio as well as his latest detailed transactions.
